Adverse events114

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 114

Type	Event	Organ system	Group	Affected	At risk	Events
other	Agitation	Psychiatric disorders	Dose Escalation - Dose Level 1, 1mcg/kg Interleukin-15 With 10 mg Avelumab	1	6	1
other	Agitation	Psychiatric disorders	Dose Level 2, 2mcg/kg Interleukin-15 With 10 mg Avelumab	0	2	0
other	Alkaline phosphatase increased	Investigations	Dose Escalation - Dose Level 1, 1mcg/kg Interleukin-15 With 10 mg Avelumab	0	6	0
other	Alkaline phosphatase increased	Investigations	Dose Level 2, 2mcg/kg Interleukin-15 With 10 mg Avelumab	2	2	2
other	Anemia	Blood and lymphatic system disorders	Dose Escalation - Dose Level 1, 1mcg/kg Interleukin-15 With 10 mg Avelumab	2	6	6
other	Anemia	Blood and lymphatic system disorders	Dose Level 2, 2mcg/kg Interleukin-15 With 10 mg Avelumab	0	2	0
other	Anorexia	Metabolism and nutrition disorders	Dose Escalation - Dose Level 1, 1mcg/kg Interleukin-15 With 10 mg Avelumab	1	6	1
other	Anorexia	Metabolism and nutrition disorders	Dose Level 2, 2mcg/kg Interleukin-15 With 10 mg Avelumab	0	2	0
other	Arthralgia	Musculoskeletal and connective tissue disorders	Dose Escalation - Dose Level 1, 1mcg/kg Interleukin-15 With 10 mg Avelumab	1	6	1
other	Arthralgia	Musculoskeletal and connective tissue disorders	Dose Level 2, 2mcg/kg Interleukin-15 With 10 mg Avelumab	0	2	0
other	Aspartate aminotransferase increased	Investigations	Dose Escalation - Dose Level 1, 1mcg/kg Interleukin-15 With 10 mg Avelumab	0	6	0
other	Aspartate aminotransferase increased	Investigations	Dose Level 2, 2mcg/kg Interleukin-15 With 10 mg Avelumab	1	2	1
other	Autoimmune disorder	Immune system disorders	Dose Escalation - Dose Level 1, 1mcg/kg Interleukin-15 With 10 mg Avelumab	1	6	1
other	Autoimmune disorder	Immune system disorders	Dose Level 2, 2mcg/kg Interleukin-15 With 10 mg Avelumab	0	2	0
other	Blood and lymphatic system disorders - Other, neutrophilia	Blood and lymphatic system disorders	Dose Escalation - Dose Level 1, 1mcg/kg Interleukin-15 With 10 mg Avelumab	1	6	2
other	Blood and lymphatic system disorders - Other, neutrophilia	Blood and lymphatic system disorders	Dose Level 2, 2mcg/kg Interleukin-15 With 10 mg Avelumab	0	2	0
other	Blood bilirubin increased	Investigations	Dose Escalation - Dose Level 1, 1mcg/kg Interleukin-15 With 10 mg Avelumab	2	6	3
other	Blood bilirubin increased	Investigations	Dose Level 2, 2mcg/kg Interleukin-15 With 10 mg Avelumab	0	2	0
other	Chills	General disorders	Dose Escalation - Dose Level 1, 1mcg/kg Interleukin-15 With 10 mg Avelumab	1	6	2
other	Chills	General disorders	Dose Level 2, 2mcg/kg Interleukin-15 With 10 mg Avelumab	0	2	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03905135/events

API reference For AI assistants

Adverse events114

Sources 3

Read this list from software.